Effects of APOE genotype on cortical atrophy in early onset Alzheimer’s disease

dc.contributor.authorChan, Diane
dc.contributor.authorBrickhouse, Michael
dc.contributor.authorZaitsev, Alexander
dc.contributor.authorWong, Bonnie
dc.contributor.authorHammers, Dustin B.
dc.contributor.authorDage, Jeffrey L.
dc.contributor.authorForoud, Tatiana M.
dc.contributor.authorEloyan, Ani
dc.contributor.authorNudelman, Kelly N.
dc.contributor.authorNemes, Sára
dc.contributor.authorCarrillo, Maria C.
dc.contributor.authorRabinovici, Gil D.
dc.contributor.authorApostolova, Liana G.
dc.contributor.authorDickerson, Bradford C.
dc.contributor.authorTouroutoglou, Alexandra
dc.contributor.authorLEADS Consortium
dc.contributor.departmentMedical and Molecular Genetics, School of Medicine
dc.date.accessioned2025-02-26T13:27:17Z
dc.date.available2025-02-26T13:27:17Z
dc.date.issued2025-01-09
dc.description.abstractBackground: APOE‐ɛ4 is a major risk factor for Alzheimer’s disease (AD); its effects have been examined in late‐onset AD (LOAD) but less so in early‐onset AD (EOAD). In LOAD, APOE genotype has strong effects on episodic memory and medial temporal lobe (MTL) atrophy (Wolk & Dickerson, 2010). However, EOAD often presents with more cognitive impairments in executive function, language, and visuospatial abilities than memory. These differences reflect more prominent atrophy in posterior lateral temporal and inferior parietal cortex that mainly constitute the EOAD‐signature of atrophy. Based on the cognitive and neuroanatomical profile of EOAD, we hypothesized that EOAD ɛ4 carriers will have relatively more atrophy in MTL regions subserving episodic memory, whereas non carriers would express more atrophy in cortical regions of the EOAD‐signature involved in executive function, language, and visuospatial abilities including inferior parietal and posterior temporal regions. We also expected worse performance on episodic memory tests in ɛ4 carriers with EOAD. Methods: We examined the effects of APOE genotype on cortical atrophy and episodic memory of 144 ɛ4 carriers and 117 ɛ4 non‐carriers with EOAD from the Longitudinal Early‐Onset Alzheimer’s Disease Study (LEADS). Between‐group comparisons using independent T‐tests were made for morphometric measures of cortical atrophy in MTL and hippocampus localized in LOAD as well as in cortical regions within our newly developed EOAD‐Signature tool (Touroutoglou et al., 2023). ANCOVA with Bonferonni’s correction was used to evaluate for effects of age on significant differences between groups. Results: As predicted, ɛ4 carriers with EOAD had more atrophy in the MTL and bilateral hippocampi, whereas non‐carriers had more atrophy in regions of the EOAD‐signature including bilateral caudal temporal, parietal lobule, middle frontal gyrus, mid temporal, posterior cingulate cortex, precuneus, superior frontal gyrus, superior parietal lobule. Post hoc vertex wise cortical maps further confirmed the specificity of the results. In addition, ɛ4 carriers had worse performance on episodic memory testing (AVLT delayed recall). These results were not explained by a difference in age between the groups. Conclusions: These results are consistent with prior work (Nemes et al. 2023) and support the hypothesis that the ɛ4 genotype modulates distinct neuroanatomic phenotypes of AD in EOAD patients.
dc.eprint.versionFinal published version
dc.identifier.citationChan D, Brickhouse M, Zaitsev A, et al. Effects of APOE genotype on cortical atrophy in early onset Alzheimer’s disease. Alzheimers Dement. 2025;20(Suppl 2):e092060. Published 2025 Jan 9. doi:10.1002/alz.092060
dc.identifier.urihttps://hdl.handle.net/1805/46066
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1002/alz.092060
dc.relation.journalAlzheimer's & Dementia
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectAPOE‐ɛ4
dc.subjectAlzheimer’s disease (AD)
dc.subjectLate‐onset AD (LOAD)
dc.subjectEarly‐onset AD (EOAD)
dc.titleEffects of APOE genotype on cortical atrophy in early onset Alzheimer’s disease
dc.typeAbstract
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Chan2025Effects-CCBY.pdf
Size:
95.23 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: